You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Kadcyla® trastuzumab emtansine

( tras-TOO-zue-mab em-TAN-seen )
Funding:
New Drug Funding Program
  • Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer as Third or Subsequent Line of Treatment (Time-Limited)
  • Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer
Other Name(s): Kadcyla® (Hoffman-LaRoche)
Appearance: clear, colourless solution

You might also be interested in